Document is current
Any future updates will be listed below
-
Authors
Stremel, Timotheus
Schnaidt, Svitlana
Bihrer, Nicole
Fröling, Emma
Jacob, Christian
Kisser, Agnes
-
Funding
Funding for this research was provided by:
Pfizer Pharma GmbH
- License Information
-
More Information
Article History
Received: 24 July 2024
Accepted: 20 November 2024
First Online: 8 December 2024
Declarations
:
: Agnes Kisser and Emma Fröling are full-time employees of Pfizer Pharma GmbH. Nicole Bihrer was an employee of Pfizer Pharma GmbH at the time of the study and completion of the manuscript, but not at the time of publication. Christian Jacob, Timotheus Stremel, and Svitlana Schnaidt are a full-time employee of Xcenda GmbH, part of Cencora Inc., acting as contractors of Pfizer Pharma GmbH for the execution of this study.
: Claims data from the participating SHIs are joined in a specialized trust center, anonymized, and transferred to InGef before the data are made available for research. The analysis of claims data from the SHI is fully compliant with German federal law and in accordance with the “GPS—Good Practice in Secondary Data Analysis” (Guideline 1: Ethics), the approval of an ethics committee and informed consent of the patients were not required.
